COMMUNIQUÉS West-GlobeNewswire
-
Annual General Meeting in ALK-Abelló A/S held on 14 March 2024
14/03/2024 - 17:40 -
Fagron publishes annual report 2023
14/03/2024 - 18:30 -
Perspectives 2024 suspendues à la suite de l’arrêt temporaire de production d’API sur le site de Brindisi en Italie
14/03/2024 - 18:55 -
Full-year 2024 guidance suspended due to the temporary pause of API production at the Brindisi site in Italy
14/03/2024 - 18:55 -
Revolutionary Study at Ibogaine By David Dardashti Sheds Light on How Zodiac Signs Impact Treatment
14/03/2024 - 19:10 -
Nuvectis Pharma Announces Encouraging Preliminary Data from the NXP800 Phase 1b Clinical Trial in Platinum-Resistant ARID1a-Mutated Ovarian Cancer
14/03/2024 - 14:00 -
BRIGHT GREEN ANNOUNCES ITS EXPANSION CONTINUATION WITH A $100 MILLION SOLAR POWERED GENERATION FIELD TO SUPPLY HEAT AND ELECTRICITY TO ITS DRUG PRODUCTION AND MANUFACTURING FACILITY.
14/03/2024 - 14:00 -
NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy
14/03/2024 - 14:00 -
Astra Plastic Surgery adds double board-certified facial plastic surgeon to acclaimed roster
14/03/2024 - 14:00 -
Y-mAbs Therapeutics Announces Resignation of Chief Financial Officer
14/03/2024 - 14:05 -
Celularity CEO to Present on Cell Therapy’s Potential to Improve Longevity at 2024 ABUNDANCE Summit
14/03/2024 - 14:15 -
ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update
14/03/2024 - 14:30 -
Revolutionizing Chronic Kidney Disease Management on World Kidney Day
14/03/2024 - 14:54 -
Rick Simpson Oil California Introduces RSO Suppositories A New Path to Wellness Through Direct Absorption
14/03/2024 - 15:13 -
SafeGuard Surgical Receives FDA "Breakthrough" Designation, Secures Funding from Tom Pepin and NFL QB Jameis Winston
14/03/2024 - 15:15 -
Sino Biological Announces Services Partnership with Rapid Novor
14/03/2024 - 15:29 -
IHA’s Symphony Chosen As Provider Directory Data Source for Covered California
14/03/2024 - 16:30 -
HepaRegeniX publishes data for its first-in-class MKK4 inhibitor HRX-215 for the treatment of acute and chronic liver diseases in Cell
14/03/2024 - 16:35 -
First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical Pipeline
14/03/2024 - 11:00
Pages